GoodRx expects to report material weaknesses in internal financial controls

GoodRx said it expects to report one or more material weaknesses in its internal control over financial reporting. The statement gave no count, no affected control areas, no timing for the assessment, and no remediation plan. A material weakness means a deficiency, or combination of deficiencies, such that there is a reasonable possibility a material misstatement of the financial statements will not be prevented or detected on a timely basis. The disclosure lands ahead of a formal filing that would carry the specific findings.